Mediocon INC supplies Similac® Plus (Follow-up Formula with Added HMO), a specialized infant nutrition product listed in India's FSSAI approved non-specified food and food ingredient records. The FSSAI approval record identifies Similac Plus (Follow up Formula with added HMO) under approval reference 40/Std/PA/FSSAI/2022, dated 04 July 2022, with Abbott Healthcare Pvt. Ltd. as the applicant.
Mediocon INC supports sourcing enquiries for the product according to applicable specifications, documentation, regulatory requirements, packaging, and commercial supply requirements.
Mediocon INC supplies Similac® Plus as a follow-up formula containing added human milk oligosaccharide (HMO). Follow-up formula is a category of infant nutrition intended for use after the infant formula stage, subject to applicable regulations and age-specific labeling.
FSSAI's current food-category framework recognizes follow-up formulae under food category 13.1.2.
Mediocon INC supplies Similac® Plus with the following general characteristics:
Mediocon INC supplies Similac® Plus as an HMO-containing follow-up formula. Human milk oligosaccharides are complex carbohydrates naturally found in human milk and are used in certain specialized infant-nutrition formulations.
The exact HMO identity, concentration, nutritional composition, and formulation should be confirmed from the current product specification and applicable regulatory documentation.
Mediocon INC supplies Similac® Plus for its intended regulated infant-nutrition application as a follow-up formula.
Because this is an infant-nutrition product, use should strictly follow the product label, applicable age requirements, preparation instructions, and advice from a qualified healthcare professional where appropriate.
Mediocon INC can assist with available product documentation, including:
Exact nutritional and analytical values should be taken from the current manufacturer's documentation and batch-specific COA rather than inferred from generic specifications.
Mediocon INC provides sourcing and commercial supply support for Similac® Plus (Follow-up Formula with Added HMO) in India, subject to applicable regulatory, distribution, and product-supply requirements.
Mediocon INC can assist with enquiries regarding product documentation, specification, packaging, quantity, and destination.
| Parameter | Specification |
|---|---|
| Appearance | Powder |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Similac® Plus (Follow-up Formula with Added HMO) Manufacturer and Supplier in India | Mediocon INC and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Similac® Plus (Follow-up Formula with Added HMO) Manufacturer and Supplier in India | Mediocon INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance